Mass cytometry analysis identified 20 separate T cell subsets, with proliferating activated CD8 T cells expressing IFNγ and GrzB to be expanded prior to tumor growth regression, indicating that a dominant and functional CD8 response is important for tumor immunity after PD-1 blockade. The gene discussed is PDCD1; the disease is neoplasm.